Clinical Trial Update: Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating SPH4336 in combination with endocrine therapy for breast cancer with brain metastases. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer with Brain Metastases

Drugs mentioned

• SPH4336

Snippet

Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd | Conditions: Breast Cancer Brain Metastases | Phase 2 | Status: RECRUITING